MALINDA KNOWLES: Open Payments
NPI 1124190475 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 17 payments from 8 companies in 2025. Trend: 2023 $554 · 2024 $209 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $136 |
| Alnylam Pharmaceuticals Inc. | 1 | $101 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| PFIZER INC. | 2 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: ONPATTRO, LINZESS, CREON, PREVNAR 20, ZEPBOUND, XIFAXAN, INJECTAFER, Wegovy.
Industry payments across CA — which companies pay providers there.
